Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its price target upped by HC Wainwright from $200.00 to $217.00 in a ...

Nuvation Bio (NYSE:NUVB – Free Report) had its target price trimmed by HC Wainwright from $11.00 to $10.00 in a research ...

H.C. Wainwright says Novo Nordisk’s REDEFINE-2 results reinforce Viking Therapeutics’ VK2735’s potential in obesity and beyond. Assuming full adherence, Novo’s CagriSema a ...

H.C. Wainwright reiterates a Buy rating and $80 price target on shares of Arrowhead (ARWR) Pharmaceuticals after the company announced top-line ...

Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call. (Operator Instructions) As a reminder, today's ...

Indian drug major Sun Pharmaceutical Industries (BSE: 524715) has entered an agreement with Checkpoint Therapeutics (Nasdaq: ...

Delving into the details, we found 46% of traders were bullish, while 39% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $524,499, and 29 were calls, valued ...

Q4 2024 Earnings Call Transcript March 6, 2025 Delcath Systems, Inc. beats earnings expectations. Reported EPS is $0.05, ...

Today, Benzinga 's options scanner spotted 32 uncommon options trades for Biogen. This isn't normal. The overall sentiment of these big-money traders is split between 37% bullish and 31%, bearish. Out ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Discover UroGen Pharma’s promising 2024 earnings call insights, with FDA progress on UGN-102 targeting $1B potential, robust pipeline updates & ...

Detailed price information for Lixte Biotech Hlds (LIXT-Q) from The Globe and Mail including charting and trades.